North America Irritable Bowel Syndrome (IBS) Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Regional Analysis

6.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue 2018-2028 (US$ Million)

6.3 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast Analysis

7. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Diagnosis

7.1 Laboratory Tests

7.1.1 Overview
7.1.2 Laboratory Tests: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.2 Imaging Tests

7.2.1 Overview
7.2.2 Imaging Tests: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

8. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Indication

8.1 Pain and Cramping

8.1.1 Overview
8.1.2 Pain and Cramping: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.2 Diarrhea

8.2.1 Overview
8.2.2 Diarrhea: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.3 Constipation

8.3.1 Overview
8.3.2 Constipation: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.4 Alternating Constipation & Diarrhea

8.4.1 Overview
8.4.2 Alternating Constipation & Diarrhea : North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

9. North America Irritable Bowel Syndrome (IBS) Diagnostics Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Key Country, 2021 and 2028 (%)
9.2.1.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 US: North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.2.1.1.2 US: North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.2.1.2 Canada: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Canada: North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.2.1.2.2 Canada: North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.2.1.3 Mexico : North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 Mexico : North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.2.1.3.2 Mexico : North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Commonwealth Diagnostics International

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Genova Diagnostics

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Gemelli Biotech

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Prometheus Laboratories

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Inova Diagnostics, Inc

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Biohit Oyj

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Aerodiagnostics, LLC.

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Metabolic Solutions, Inc

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Sysmex Corporation (Sysmex Europe GmbH)

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 BÜHLMANN Laboratories AG

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Irritable Bowel Syndrome (IBS) Diagnostics Market

Analysis By Diagnosis (Laboratory Tests, and Imaging Tests), and Indication (Pain and Cramping, Diarrhea, Constipation, and Alternating Constipation & Diarrhea)